Literature DB >> 8593009

Analysis of ceftriaxone and ceftazidime distribution in cerebrospinal fluid of and cerebral extracellular space in awake rats by in vivo microdialysis.

L Granero1, M Santiago, J Cano, A Machado, J E Peris.   

Abstract

In vivo microdialysis was used to estimate the extracellular concentrations of ceftazidime and ceftriaxone, two expanded-spectrum cephalosporins commonly used in the treatment of bacterial meningitis, in two brain regions (the right corpus striatum and the left lateral ventricle_ of awake, freely moving rats. Antibiotics were administered by constant intravenous infusion at 18 mg/h until steady-state levels were reached. Ceftriaxone levels measured at the steady state in the extracellular space of the corpus striatum (0.80 +/- 0.17 micrograms/ml) were statistically equivalent to those obtained in the cerebrospinal fluid of the lateral ventricle (0.71 +/- 0.15 micrograms/ml). The ratios of these levels in the brain to the steady-state levels in plasma were 0.5 +/- 0.1% for both regions. The postinfusion concentrations of ceftriaxone in the brain declined monoexponentially, with an elimination half-life similar to that obtained in plasma. However, the mean antibiotic concentration of ceftazidime in the striatum (2.2 +/- 0.4 micrograms/ml) was lower (P < 0.001) than that in the lateral ventricle (3.8 +/- 0.5% and 4.0 +/- 1.8%, respectively) were higher than those obtained with ceftriaxone. Moreover, the half-life of ceftazidime elimination from plasma was lower than that obtained in the two brain regions. It was concluded that the in vivo microdialysis technique yields useful data on antibiotic distribution in the extracellular space of the brain, that the distribution may not be homogeneous, and that the decay of postinfusion concentrations in the brain may be different from the decay of postinfusion concentrations in plasma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8593009      PMCID: PMC163019          DOI: 10.1128/AAC.39.12.2728

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  In vivo microdialysis sampling for pharmacokinetic investigations.

Authors:  D O Scott; L R Sorenson; K L Steele; D L Puckett; C E Lunte
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

2.  The relation between plasma and tissue concentrations of antibiotics. Description of a method.

Authors:  H Mattie; J J Hoogeterp; J Hermans
Journal:  J Pharmacokinet Biopharm       Date:  1987-04

3.  Hospital routine analysis of penicillins, third-generation cephalosporins and aztreonam by conventional and high-speed high-performance liquid chromatography.

Authors:  F Jehl; P Birckel; H Monteil
Journal:  J Chromatogr       Date:  1987-01-23

4.  Penetration of ceftazidime into the cerebrospinal fluid of patients with and without evidence of meningeal inflammation.

Authors:  I W Fong; K B Tomkins
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

5.  Penetration of ceftazidime into cerebrospinal fluid of patients with bacterial meningitis.

Authors:  J Modai; D Vittecoq; J M Decazes; M Wolff; A Meulemans
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

6.  Pharmacokinetics and tissue penetration of ceftazidime: studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid.

Authors:  R A Walstad; K B Hellum; S Blika; L G Dale; T Fredriksen; K I Myhre; G R Spencer
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

7.  Mass transfer in brain dialysis devices--a new method for the estimation of extracellular amino acids concentration.

Authors:  I Jacobson; M Sandberg; A Hamberger
Journal:  J Neurosci Methods       Date:  1985 Nov-Dec       Impact factor: 2.390

8.  Modeling of the effect site equilibration kinetics and pharmacodynamics of racemic baclofen and its enantiomers using quantitative EEG effect measures.

Authors:  J W Mandema; C D Heijligers-Feijen; E Tukker; A G De Boer; M Danhof
Journal:  J Pharmacol Exp Ther       Date:  1992-04       Impact factor: 4.030

9.  Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes.

Authors:  M Santiago; B H Westerink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

Review 10.  Clinical significance of antibiotic tissue penetration.

Authors:  J J Schentag
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

View more
  12 in total

Review 1.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.

Authors:  Markus Müller; Amparo dela Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

2.  Postneurosurgical meningitis due to Proteus penneri with selection of a ceftriaxone-resistant isolate: analysis of chromosomal class A beta-lactamase HugA and its LysR-type regulatory protein HugR.

Authors:  Nadia Liassine; Stéphanie Madec; Béatrice Ninet; Catherine Metral; Martine Fouchereau-Peron; Roger Labia; Raymond Auckenthaler
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

Review 3.  Application of microdialysis in pharmacokinetic studies.

Authors:  W F Elmquist; R J Sawchuk
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

4.  β-Lactam antibiotic produces a sustained reduction in extracellular glutamate in the nucleus accumbens of rats.

Authors:  Bruce A Rasmussen; David A Baron; Jae K Kim; Ellen M Unterwald; Scott M Rawls
Journal:  Amino Acids       Date:  2010-04-13       Impact factor: 3.520

5.  The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats.

Authors:  S M Rawls; R Tallarida; W Robinson; M Amin
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

6.  Lung microdialysis study of levofloxacin in rats following intravenous infusion at steady state.

Authors:  Sandrine Marchand; Denis Frasca; Claire Dahyot-Fizelier; Céline Breheret; Olivier Mimoz; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

7.  Rifampin concentrations in various compartments of the human brain: a novel method for determining drug levels in the cerebral extracellular space.

Authors:  T Mindermann; W Zimmerli; O Gratzl
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

8.  Effects of ceftriaxone on ethanol drinking and GLT-1 expression in ethanol dependence and relapse drinking.

Authors:  William C Griffin; Harold L Haun; Vorani S Ramachandra; Lori A Knackstedt; Patrick J Mulholland; Howard C Becker
Journal:  Alcohol       Date:  2021-01-16       Impact factor: 2.405

9.  Effect of P-glycoprotein Inhibition on the Penetration of Ceftriaxone Across the Blood-Brain Barrier.

Authors:  Yuheng Shan; Yuying Cen; Yanjin Zhang; Ruishu Tan; Jiahua Zhao; Zhiyong Nie; Jiatang Zhang; Shengyuan Yu
Journal:  Neurochem Res       Date:  2021-10-25       Impact factor: 3.996

Review 10.  Utility of CSF in translational neuroscience.

Authors:  Elizabeth C M de Lange
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-02-12       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.